TEMAZ

This brand name is authorized in Nigeria.

Active ingredients

The drug TEMAZ contains one active pharmaceutical ingredient (API):

1
UNII U5SYW473RQ - TELMISARTAN
 

Telmisartan is an orally active and specific angiotensin II receptor (type AT1) antagonist. Telmisartan selectively binds the AT1 receptor. The binding is long-lasting.
 
Read more about Telmisartan

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
B4-6339 Tablet Temaz 40 Tablets TAB 40 mg 28/10/2021
B4-6340 Tablet Temaz 80 Tablets TAB 80 mg 28/10/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
C09CA07 Telmisartan C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09C Angiotensin II antagonists, plain → C09CA Angiotensin II antagonists, plain
Discover more medicines within C09CA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database B4-6339, B4-6340

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈